Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the adult vaccines market size evolved in recent years?

In the past few years, the adult vaccines market has seen robust growth. The industry is expected to expand from a worth of $22.82 billion in 2024 to $24.49 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth in the historic period include an increase in the elderly population, government-backed vaccination initiatives, heightened awareness regarding preventative healthcare, progress in vaccine development and innovation, and public health awareness campaigns.

What are the predictions for the adult vaccines market size in the coming years?

There is anticipated robust expansion in the adult vaccines market in the coming years. The market is projected to escalate to $35.22 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 9.5%. This growth during the projected period can be credited to the advent of new infectious diseases, the growing emphasis on immunization databases, the escalating threat of antimicrobial defiance, global initiatives for pandemic readiness, the shift towards tailor-made vaccines, and an augmented focus on maternal vaccination. Major trends during the prediction period encompass the integration of digital health, technological progress in vaccine manufacturing, partnerships between governments and pharmaceutical firms, advancements in vaccine distribution technologies, and the expansion of immunization schemes.

Get your adult vaccines market report here!

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

What key factors are fueling the growth of the adult vaccines market?

The surge in infectious diseases is propelling the growth of the adult vaccine market. Infectious diseases are those that can be passed from one individual to another. Vaccines serve as a highly efficient tool in battling these diseases as they bolster an individual’s immunity against them. For example, the Centers for Disease Control and Prevention, a national public health organization based in the U.S., reported that in the year 2022, tuberculosis cases in the U.S. increased to 8,300 from 7,874 in 2021. The incidence rate of TB in 2022 also experienced a slight rise to 2.5 per 100,000 people as opposed to 2.4 in the previous year. As a result, the escalating frequency of infectious diseases is fueling the expansion of the adult vaccine market.

How is the global adult vaccines market divided into key segments?

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

Who are the key firms paving the way for growth in the adult vaccines market?

Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Which trends are expected to transform the adult vaccines market?

In the adult vaccines market, one of the primary trends that’s becoming increasingly popular is product innovation. Leading companies in the market have been rolling out inventive products to maintain their market standing. For example, a biopharma company based in the UK known as GSK, along with IQVIA, a global supplier of advanced analytics, technology solutions and clinical research services from India, unveiled Vaccine Track in August 2022. This data trend platform is aimed at boosting adult vaccination in communities across the country. The platform will consistently supply applicable data about trends so as to bolster initiatives in public health.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9038

What regions are contributing significantly to the growth of the adult vaccines market?

North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Network Engineering Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/network-engineering-services-global-market-report

Power Generators Global Market Report 2023

https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

Software Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/software-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: